Radiation Oncology/Therapy: Page 34

IBA acquires Modus Medical Devices

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) has purchased Canadian dosimetry phantom provider Modus Medical Devices.

May 2, 2022

CIVCO plans new RT platform launch at ESTRO

By AuntMinnie.com staff writers

Radiation therapy (RT) products provider CIVCO Radiotherapy will be introducing its TotalRT platform at the European Society for Radiotherapy and Oncology (ESTRO) meeting in Denmark this week.

May 2, 2022

Qsam doses first patient in Cyclosam clinical trial

By AuntMinnie.com staff writers

Qsam Biosciences said the first patient has begun treatment in the company's clinical trial evaluating samarium-153-DOTMP (CycloSam) for the treatment of bone cancer and related diseases.

April 28, 2022

Accuray sees Q3 revenues decreases, names new CEO

By AuntMinnie.com staff writers

Accuray released financial results for the third quarter of the 2022 fiscal year showing a decline in revenue from the previous year. The company also announced promotions, including a new CEO.

April 28, 2022

Vuno signs R&D deal with Mayo Clinic for precision oncology

By AuntMinnie.com staff writers

South Korean artificial intelligence (AI) software developer Vuno has signed a research and development agreement with Mayo Clinic in which the parties will work together to develop AI for precision oncology.

April 21, 2022

Midtherapy PET/CT predicts response in patients with esophageal cancer

By Will Morton

Performing PET/CT scans while patients are undergoing radiotherapy prior to surgery for esophageal cancer can help predict whether they will respond to treatment, according to a study published April 18 in Radiotherapy and Oncology.

April 21, 2022

Dual-tracer PET/CT shows promise in cancer imaging

By Will Morton

Two PET/CT radiotracers -- F-18 FDG and gallium-68 FAPI-46 -- work better together than when used alone for cancer imaging, according to a proof-of-concept study published April 14 in the Journal of Nuclear Medicine.

April 19, 2022

Radsource installs ProtonPACS in Q1

By AuntMinnie.com staff writers

Radsource completed 11 installations of its ProtonPACS software at new and existing customers in the first quarter of 2022, the company said.

April 14, 2022

ITM, MTTI ink lutetium-177 supply deal

By AuntMinnie.com staff writers

ITM Isotope Technologies Munich's subsidiary ITM Medical Isotopes and biopharmaceutical company Molecular Targeting Technologies (MTTI) have signed a supply deal for no-carrier-added lutetium-177.

April 12, 2022

NYSE accepts Navidea bid to comply with stock listing rules

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals said the New York Stock Exchange (NYSE) has accepted its plan to regain compliance with the stock exchange's listing requirements. Navidea now has until July 28, 2023, to regain compliance.

April 12, 2022

Radionetics Oncology taps de Silva as CEO

By AuntMinnie.com staff writers

Pharmaceutical firm Radionetics Oncology has named Dr. Nishan de Silva as CEO and a director of the company's board. De Silva most recently was with AFYX Therapeutics.

April 11, 2022

FDA clears clinical trial for Blue Earth radiopharmaceutical

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has given the go-ahead to Blue Earth Therapeutics to conduct a clinical study of its radiopharmaceutical labeled with lutetium-177 for treatment of metastatic, castrate-resistant prostate cancer.

April 11, 2022

Previous Page

Page 34 of 466

Next Page